Researchers review the associations between following a Mediterranean diet and sleep quality.
New Options Challenge Standard Treatments in EGFR-Mutant NSCLC
MADRID — Two positive phase III trials involving amivantamab (Rybrevant)-based regimens introduced new first- and second-line options in EGFR-mutant non-small cell lung cancer (NSCLC), though